IRIS Accounts Production v24.3.2.46 06927650 Board of Directors 1.4.23 31.3.24 31.3.24 Medium entities the provision of healthcare services. 190 164 true false true true false false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069276502023-03-31069276502024-03-31069276502023-04-012024-03-31069276502022-03-31069276502022-04-012023-03-31069276502023-03-3106927650ns15:EnglandWales2023-04-012024-03-3106927650ns14:PoundSterling2023-04-012024-03-3106927650ns10:Director12023-04-012024-03-3106927650ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3106927650ns10:MediumEntities2023-04-012024-03-3106927650ns10:Audited2023-04-012024-03-3106927650ns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-04-012024-03-3106927650ns10:Medium-sizedCompaniesRegimeForAccounts2023-04-012024-03-3106927650ns10:FullAccounts2023-04-012024-03-310692765012023-04-012024-03-3106927650ns10:OrdinaryShareClass22023-04-012024-03-3106927650ns10:OrdinaryShareClass32023-04-012024-03-3106927650ns10:Director32023-04-012024-03-3106927650ns10:Director42023-04-012024-03-3106927650ns10:Director52023-04-012024-03-3106927650ns10:Director62023-04-012024-03-3106927650ns10:Director72023-04-012024-03-3106927650ns10:Director92023-04-012024-03-3106927650ns10:Director102023-04-012024-03-3106927650ns10:Director112023-04-012024-03-3106927650ns10:Director122023-04-012024-03-3106927650ns10:CompanySecretary12023-04-012024-03-3106927650ns10:RegisteredOffice2023-04-012024-03-3106927650ns10:Director22023-04-012024-03-3106927650ns10:Director82023-04-012024-03-310692765012023-04-012024-03-310692765012022-04-012023-03-3106927650ns5:CurrentFinancialInstruments2024-03-3106927650ns5:CurrentFinancialInstruments2023-03-3106927650ns5:ShareCapital2024-03-3106927650ns5:ShareCapital2023-03-3106927650ns5:SharePremium2024-03-3106927650ns5:SharePremium2023-03-3106927650ns5:CapitalRedemptionReserve2024-03-3106927650ns5:CapitalRedemptionReserve2023-03-3106927650ns5:RetainedEarningsAccumulatedLosses2024-03-3106927650ns5:RetainedEarningsAccumulatedLosses2023-03-3106927650ns5:ShareCapital2022-03-3106927650ns5:RetainedEarningsAccumulatedLosses2022-03-3106927650ns5:SharePremium2022-03-3106927650ns5:CapitalRedemptionReserve2022-03-3106927650ns5:ShareCapital2022-04-012023-03-3106927650ns5:SharePremium2022-04-012023-03-3106927650ns5:RetainedEarningsAccumulatedLosses2022-04-012023-03-3106927650ns5:CapitalRedemptionReserve2022-04-012023-03-3106927650ns5:ShareCapital2023-04-012024-03-3106927650ns5:SharePremium2023-04-012024-03-3106927650ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-3106927650ns5:CapitalRedemptionReserve2023-04-012024-03-3106927650ns5:NetGoodwill2023-04-012024-03-3106927650ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3106927650ns5:PlantMachinery2023-04-012024-03-3106927650ns5:FurnitureFittings2023-04-012024-03-3106927650ns5:ComputerEquipment2023-04-012024-03-3106927650ns5:ReportableOperatingSegment12023-04-012024-03-3106927650ns5:ReportableOperatingSegment12022-04-012023-03-3106927650ns5:ReportableOperatingSegment22023-04-012024-03-3106927650ns5:ReportableOperatingSegment22022-04-012023-03-3106927650ns5:ReportableOperatingSegment32023-04-012024-03-3106927650ns5:ReportableOperatingSegment32022-04-012023-03-3106927650ns5:ReportableOperatingSegment42023-04-012024-03-3106927650ns5:ReportableOperatingSegment42022-04-012023-03-3106927650ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-04-012024-03-3106927650ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2022-04-012023-03-3106927650ns10:HighestPaidDirector2023-04-012024-03-3106927650ns10:HighestPaidDirector2022-04-012023-03-3106927650ns5:OwnedAssets2023-04-012024-03-3106927650ns5:OwnedAssets2022-04-012023-03-3106927650ns5:NetGoodwill2022-04-012023-03-310692765022022-04-012023-03-3106927650ns10:OrdinaryShareClass22022-04-012023-03-3106927650ns5:NetGoodwill2023-03-3106927650ns5:NetGoodwill2024-03-3106927650ns5:NetGoodwill2023-03-3106927650ns5:PlantMachinery2023-03-3106927650ns5:FurnitureFittings2023-03-3106927650ns5:ComputerEquipment2023-03-3106927650ns5:PlantMachinery2024-03-3106927650ns5:FurnitureFittings2024-03-3106927650ns5:ComputerEquipment2024-03-3106927650ns5:PlantMachinery2023-03-3106927650ns5:FurnitureFittings2023-03-3106927650ns5:ComputerEquipment2023-03-3106927650ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3106927650ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3106927650ns5:WithinOneYear2024-03-3106927650ns5:WithinOneYear2023-03-3106927650ns5:DeferredTaxation2023-03-3106927650ns5:DeferredTaxation2023-04-012024-03-3106927650ns5:DeferredTaxation2024-03-3106927650ns10:OrdinaryShareClass22024-03-3106927650ns10:OrdinaryShareClass32024-03-3106927650ns5:RetainedEarningsAccumulatedLosses2023-03-3106927650ns5:SharePremium2023-03-3106927650ns5:CapitalRedemptionReserve2023-03-31
REGISTERED NUMBER: 06927650 (England and Wales)









DORKING HEALTHCARE LIMITED

STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024






DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 8

Other Comprehensive Income 9

Balance Sheet 10

Statement of Changes in Equity 11

Cash Flow Statement 12

Notes to the Financial Statements 13


DORKING HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Mr M A Arnaud
Dr S J Tomlinson
Dr A J Beattie
Dr V Sagar
Dr E M Moffett
Dr M E D Ince
Mrs J V Millman
Mrs F R Laws
Mr D D Ross
Dr S A Johnson


SECRETARY: MC Secretaries Limited


REGISTERED OFFICE: DHC GP Federation
Holmhurst Medical Centre
12 Thornton Side
Redhill
Surrey
RH1 2NP


REGISTERED NUMBER: 06927650 (England and Wales)


SENIOR STATUTORY AUDITOR: Steve Nichols


INDEPENDENT AUDITORS: Nichols & Co (Accountancy) Limited
Unit 7
Mulberry Place
Pinnell Road, Eltham
London
SE9 6AR


ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2024

The directors present their strategic report for the year ended 31 March 2024.

REVIEW OF BUSINESS
DHC is a GP Federation providing NHS services in Surrey. The main services are outpatients and talking therapies which are delivered under contracts with Surrey Heartland Integrated Care Board (ICB). DHC is owned by the local GP practices and DHC also provides support services for those practices and the Primary Care Networks (PCNs) formed from those practices.

PRINCIPAL RISKS AND UNCERTAINTIES
The principal risks arise from the NHS being the single commissioner of services from DHC and the inherent risks from being reliant on a single customer. DHC has been providing services within Surrey for nearly 20 years and works closely with the ICB to deliver the right services for the local population.

DEVELOPMENT AND PERFORMANCE
In 2023/24, our activity levels in outpatients expanded considerably. It was also a year of considerable investment for the future, including the purchase of Surrey Ultrasound Services and increasing the capacity and capability of our management, medical, administrative, nursing and talking therapies teams.

FINANCIAL KEY PERFORMANCE INDICATORS
In outpatients there was a 23% increase in the number of referrals received which led to a 15% increase in the number of appointments. In talking therapies there was a 3% increase in the number of referrals received which led to a 1% increase in the number of clients completing treatment.

ON BEHALF OF THE BOARD:





Mr M A Arnaud - Director


20 March 2025

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MARCH 2024

The directors present their report with the financial statements of the company for the year ended 31 March 2024.

DIVIDENDS
The total distribution of dividends for the year ended 31 March 2024 will be £470,000.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2023 to the date of this report.

Mr M A Arnaud
Dr S J Tomlinson
Dr A J Beattie
Dr V Sagar
Dr E M Moffett
Dr M E D Ince
Mrs J V Millman
Mrs F R Laws
Mr D D Ross
Dr S A Johnson

Other changes in directors holding office are as follows:

Dr J D Richards - resigned 31 January 2024

Mrs M V Godfrey ceased to be a director after 31 March 2024 but prior to the date of this report.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MARCH 2024


AUDITORS
The auditors, Nichols & Co (Accountancy) Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Mr M A Arnaud - Director


20 March 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
DORKING HEALTHCARE LIMITED

Opinion
We have audited the financial statements of Dorking Healthcare Limited (the 'company') for the year ended 31 March 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2024 and of its loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
DORKING HEALTHCARE LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

From discussion with management and those charged with governance information about the entity is documented to assess the activity within the organisation. We discuss management's assessment of risk in respect of irregularities, fraud and going concern.

Based on these discussions and our own assessments we determined that the key risk areas were income recognition in respect of cut off issues and management override concerning the size of the organisation.

We set financial statement materiality level based on the level of income. As a not for profit organisation raising income is its primary focus which is why income was used to determine the level of materiality. Our overall assessment of risk was used to determine performance materiality at an appropriate level.

Substantive audit tests were designed after assessing and performing walkthrough tests. The walkthrough testing confirmed documented systems which have been designed to act as a preventative measure against fraud and error which appear to be operating as documented. Substantive testing tested a sample of the population, representative of the population, to identify errors. The testing did not identify any material misstatements in areas tested.

Audit substantive tests concluded no material errors over the key risk areas of income recognition and management override.

The audit considers the organisation is not exposed to material risk of error as a result of assessing laws and regulations that are appropriate to the organisation.

Management assessed there is no going concern risk. The audit undertook a review of budgets, management accounts and the review of board minutes and came to the same conclusion as management.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
DORKING HEALTHCARE LIMITED


Other matters required to address
The comparative figures included in these financial statements are unaudited.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Steve Nichols (Senior Statutory Auditor)
for and on behalf of Nichols & Co (Accountancy) Limited
Unit 7
Mulberry Place
Pinnell Road, Eltham
London
SE9 6AR

20 March 2025

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

INCOME STATEMENT
FOR THE YEAR ENDED 31 MARCH 2024

2024 2023
as restated
Notes £    £   

TURNOVER 3 13,647,553 11,989,199

Cost of sales 10,329,359 8,444,478
GROSS PROFIT 3,318,194 3,544,721

Administrative expenses 3,545,085 2,557,383
(226,891 ) 987,338

Other operating income 11,728 5,000
OPERATING (LOSS)/PROFIT 5 (215,163 ) 992,338


Interest payable and similar expenses 7 - 376
(LOSS)/PROFIT BEFORE TAXATION (215,163 ) 991,962

Tax on (loss)/profit 8 (37,312 ) 199,808
(LOSS)/PROFIT FOR THE FINANCIAL
YEAR

(177,851

)

792,154

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2024

2024 2023
as restated
Notes £    £   

(LOSS)/PROFIT FOR THE YEAR (177,851 ) 792,154


OTHER COMPREHENSIVE INCOME
Share adjustments 2 (13,660 )
Income tax relating to other
comprehensive income

-

-

OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

2

(13,660

)
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

(177,849

)

778,494

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

BALANCE SHEET
31 MARCH 2024

2024 2023
as restated
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 12 223,921 113,025
Tangible assets 13 343,162 318,656
567,083 431,681

CURRENT ASSETS
Debtors 14 1,515,218 2,987,731
Cash at bank and in hand 709,878 755,486
2,225,096 3,743,217
CREDITORS
Amounts falling due within one year 15 1,527,425 2,282,143
NET CURRENT ASSETS 697,671 1,461,074
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,264,754

1,892,755

PROVISIONS FOR LIABILITIES 17 85,238 78,802
NET ASSETS 1,179,516 1,813,953

CAPITAL AND RESERVES
Called up share capital 18 47 48
Share premium 19 165,263 151,850
Capital redemption reserve 19 12 10
Retained earnings 19 1,014,194 1,662,045
SHAREHOLDERS' FUNDS 1,179,516 1,813,953

The financial statements were approved by the Board of Directors and authorised for issue on 20 March 2025 and were signed on its behalf by:





Mr M A Arnaud - Director


DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2024

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 April 2022 36 1,353,551 42,403 9 1,395,999

Changes in equity
Issue of share capital 12 - 109,447 - 109,459
Dividends - (470,000 ) - - (470,000 )
Total comprehensive income - 778,494 - 1 778,495
Balance at 31 March 2023 48 1,662,045 151,850 10 1,813,953

Changes in equity
Issue of share capital (1 ) - 13,413 - 13,412
Dividends - (470,000 ) - - (470,000 )
Total comprehensive income - (177,851 ) - 2 (177,849 )
Balance at 31 March 2024 47 1,014,194 165,263 12 1,179,516

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 MARCH 2024

2024 2023
as restated
Notes £    £   
Cash flows from operating activities
Cash generated from operations 21 798,242 176,025
Interest paid - (376 )
Tax paid (123,104 ) (156,635 )
Net cash from operating activities 675,138 19,014

Cash flows from investing activities
Purchase of intangible fixed assets (120,796 ) -
Purchase of tangible fixed assets (143,364 ) (190,560 )
Net cash from investing activities (264,160 ) (190,560 )

Cash flows from financing activities
Share issue 1 (13,646 )
Share premium 13,413 109,447
Equity dividends paid (470,000 ) (470,000 )
Net cash from financing activities (456,586 ) (374,199 )

Decrease in cash and cash equivalents (45,608 ) (545,745 )
Cash and cash equivalents at
beginning of year

22

755,486

1,301,231

Cash and cash equivalents at end of
year

22

709,878

755,486

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

Dorking Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The comparative figures included in these financial statements for year ended 31 March 2023 are unaudited.

Turnover
Turnover represents sales of healthcare services undertaken during the period and is recognised at the point when the company satisfies a performance obligation to a customer as agreed. This is applicable for all main categories of turnover.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2014, is being
amortised evenly over its estimated useful life of twenty years.

Additional goodwill was acquired during the year and will be amortised from 1st April 2024.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method


DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of
Income and Retained Earnings, except to the extent that it relates to items recognised in other
comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. TURNOVER

The turnover and loss (2023 - profit) before taxation are attributable to the principal activities of the company.

An analysis of turnover by class of business is given below:

2024 2023
as restated
£    £   
Outpatient services 7,076,107 6,102,736
Talking therapies services 4,100,295 3,386,277
Pond tail income 1,288,756 1,474,669
Projects & management income 1,182,395 1,025,517
13,647,553 11,989,199

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was as follows:

20242023
as
restated
££

Employees190164

The allocation of employee and director costs were as follows:

20242023
as
restated
££
Wages and salaries5,723,0714,674,719
Social security costs572,965463,027
Pension costs725,633581,901

Total7,023,6935,721,670


2024 2023
as restated
£    £   
Directors' remuneration 699,718 699,394

Information regarding the highest paid director is as follows:
2024 2023
as restated
£    £   
Emoluments etc 175,380 138,433

The highest paid director did not exercise any share options and no shares were received or
receivable by that director in respect of qualifying services under a long term incentive scheme.

The total company pension contributions paid in respect of directors amounted to £44,403 (2023: £34,959)

5. OPERATING (LOSS)/PROFIT

The operating loss (2023 - operating profit) is stated after charging:

2024 2023
as restated
£    £   
Other operating leases 48,000 24,000
Depreciation - owned assets 118,858 112,718
Goodwill amortisation 9,900 9,900

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

6. AUDITORS' REMUNERATION
2024 2023
as restated
£    £   
Fees payable to the company's auditors for the audit of the
company's financial statements

20,500

-

7. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
as restated
£    £   
Bank interest - 376

8. TAXATION

Analysis of the tax (credit)/charge
The tax (credit)/charge on the loss for the year was as follows:
2024 2023
as restated
£    £   
Current tax:
UK corporation tax (43,748 ) 166,137

Deferred tax 6,436 33,671
Tax on (loss)/profit (37,312 ) 199,808

Reconciliation of total tax (credit)/charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2024 2023
as restated
£    £   
(Loss)/profit before tax (215,163 ) 991,962
(Loss)/profit multiplied by the standard rate of corporation tax in the
UK of 19% (2023 - 19%)

(40,881

)

188,473

Effects of:
Expenses not deductible for tax purposes - 1,548
Capital allowances in excess of depreciation (2,867 ) (23,884 )
Deferred tax movement in respect of timing differences 6,436 33,671
Total tax (credit)/charge (37,312 ) 199,808

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

8. TAXATION - continued

Tax effects relating to effects of other comprehensive income

2024
Gross Tax Net
£    £    £   
Share adjustments 2 - 2

2023
Gross Tax Net
£    £    £   
Retained earnings (13,660 ) - (13,660 )
Capital redemption reserve 1 - 1
(13,659 ) - (13,659 )

Finance Bill 2021 was substantively enacted on 24 May 2021 so from 1 April 2023 the main rate of
corporation tax in the UK will increase to 25% for businesses with profits over £250,000, with a
marginal rate between that and profits under £50,000, which will continue to be taxed at 19%.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the
period when the asset is realised or the liability is settled, based on the tax rates that have been
substantively enacted at the balance sheet date.

9. DIVIDENDS
2024 2023
as restated
£    £   
Ordinary A shares of £1 each
Interim 470,000 470,000

10. PRIOR YEAR ADJUSTMENT

During the year a number of provisions and balances totalling £226,486 were written back as they are no longer required. Since these items are material, and relate to accounting periods before 1 April 2023, the write back has been made in the previous year. The comparative figures in these accounts have been restated to incorporate the adjustment. This is in accordance with UK Generally Accepted Accounting Principles and Financial Reporting Standard 102.

Profit before tax for the year ended 31 March 2023 has increased by £226,486, resulting in an additional corporation tax liability of £43,032.

11. GRANT

Grants received totalling £25,000 have been reflected under the performance model, the corresponding charge to income of £5,000 is a reflection of the 20% reducing balance depreciation charge on the fixed asset for which the grant was intended to be used.

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

12. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023 198,000
Additions 120,796
At 31 March 2024 318,796
AMORTISATION
At 1 April 2023 84,975
Amortisation for year 9,900
At 31 March 2024 94,875
NET BOOK VALUE
At 31 March 2024 223,921
At 31 March 2023 113,025

Goodwill of £120,796 was acquired on 28 March 2024 and relates to the purchase of the business and assets of Surrey Ultrasound Services Ltd.

13. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2023 431,018 156,338 288,854 876,210
Additions 82,507 9,425 51,432 143,364
At 31 March 2024 513,525 165,763 340,286 1,019,574
DEPRECIATION
At 1 April 2023 244,003 87,282 226,269 557,554
Charge for year 43,223 19,620 56,015 118,858
At 31 March 2024 287,226 106,902 282,284 676,412
NET BOOK VALUE
At 31 March 2024 226,299 58,861 58,002 343,162
At 31 March 2023 187,015 69,056 62,585 318,656

Within plant and machinery additions there is a £53,404 purchase for Ultrasound Imaging equipment which has been acquired through business combination.

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

14. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Trade debtors 341,498 773,140
Other debtors 90,455 226,487
Pond Tail Assets 157,124 220,078
Corporation tax recoverable 43,748 -
Accrued Income 772,595 1,555,361
Prepayments 109,798 212,665
1,515,218 2,987,731

15. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Trade creditors 565,398 295,187
Wages control account - (3,267 )
Pond Tail liabilities 31,034 92,369
Corporation tax 43,033 166,137
Social security and other taxes 206,747 168,459
Other creditors 4,330 429,090
Dorking Healthcare LLP 13,761 43,490
Pensions control account 152,360 122,368
Grants 5,000 10,000
PCN Accounts - 170,777
Deferred income 230,918 473,442
Accrued expenses 274,844 314,091
1,527,425 2,282,143

16. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
as restated
£    £   
Within one year 48,000 48,000

Rent is payable quarterly, in advance for an amount of £12,000 (2023: £12,000).

17. PROVISIONS FOR LIABILITIES
2024 2023
as restated
£    £   
Deferred tax 85,238 78,802

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

17. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 April 2023 78,802
Provided during year 6,436
Balance at 31 March 2024 85,238

18. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: as
restated
£    £   
46 Ordinary A £1 46 47
1 Ordinary B £1 1 1
47 48

19. RESERVES
Capital
Retained Share redemption
earnings premium reserve Totals
£    £    £    £   

At 1 April 2023 1,662,045 151,850 10 1,813,905
Deficit for the year (177,851 ) (177,851 )
Dividends (470,000 ) (470,000 )
Cash share issue - 13,413 2 13,415
At 31 March 2024 1,014,194 165,263 12 1,179,469

20. PENSION COMMITMENTS

The company operates a defined contribution pension scheme. The assets of the scheme are held
separately from those of the company in an independently administered fund.

The pension cost charge represents contributions payable by the company to the fund and amounted to £226,351 (2023: £160,527).

Commitments of £152,360 were payable to the fund at 31 March 2024 (2023: £122,368).

The amount of commitments that are not reflected in the balance sheet is £nil (2023: £nil).

The amount of pension commitments that relate to past directors is £nil (2023: £nil).

DORKING HEALTHCARE LIMITED (REGISTERED NUMBER: 06927650)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

21. RECONCILIATION OF (LOSS)/PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2024 2023
as restated
£    £   
(Loss)/profit before taxation (215,163 ) 991,962
Depreciation charges 128,758 122,617
Finance costs - 376
(86,405 ) 1,114,955
Decrease/(increase) in trade and other debtors 1,516,261 (905,876 )
Decrease in trade and other creditors (631,614 ) (33,054 )
Cash generated from operations 798,242 176,025

22. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2024
31.3.24 1.4.23
£    £   
Cash and cash equivalents 709,878 755,486
Year ended 31 March 2023
31.3.23 1.4.22
as restated
£    £   
Cash and cash equivalents 755,486 1,301,231


23. ANALYSIS OF CHANGES IN NET FUNDS

At 1.4.23 Cash flow At 31.3.24
£    £    £   
Net cash
Cash at bank and in hand 755,486 (45,608 ) 709,878
755,486 (45,608 ) 709,878
Total 755,486 (45,608 ) 709,878